Gene Therapy in Ophthalmology Update 9: Oxford BioMedica/OHSU Preparing to Treat First Usher Syndrome Patient & Oxford BioMedica Ophthalmic Program Update

In an announcement today from the Foundation Fighting Blindness, and confirmed by Oxford BioMedica, the Casey Eye Institute of the Oregan Health & Science University (OHSU) is preparing to treat the first Usher Syndrome patient under the clinical protocol designed by Oxford BioMedica using its UshStat gene therapy treatment.


Here is the complete text of the FFB news release:


March 6, 2012 - The first-ever (Read more...)

Full Story →